Prostate cancer epigenetics and its clinical implications

Area of Science:

• Molecular Biology
• Cancer Genomics
• Epigenetics

Background:

• Epigenetic programming, akin to an architectural cityscape, regulates genome structure and function.
• Abnormalities in genetic and epigenetic landscapes cooperate in carcinogenesis.
• Mutations in epigenetic machinery genes are common in cancers, including prostate cancer.

Purpose of the Study:

• To explore epigenetic principles in normal and prostate cancer cells.
• To discuss clinical implications for prostate cancer biomarker development and therapy.

Main Methods:

• Review of basic principles of epigenetic processes.
• Analysis of large-scale cancer genome sequencing data.
• Discussion of clinical implications.

Main Results:

• Epigenetic alterations are highly recurrent and nearly universal in prostate cancer.
• Genetic mutations in epigenetic machinery are frequent in human cancers.
• Epigenetic alterations present opportunities for biomarkers and therapeutics.

Conclusions:

• Understanding epigenetic processes is crucial for cancer research.
• Recurrent epigenetic alterations in prostate cancer can be leveraged for clinical applications.
• Epigenetics offers promising avenues for prostate cancer detection, risk stratification, and treatment.